Nonoccupational Postexposure Prophylaxis (nPEP) Visits: Opportunities Beyond HIV PEP

by Brian R. Wood
Published 2015-11-01

Increased risk of virologic rebound in patients on antiviral therapy with a detectable HIV load <48 copies/mL.

by Timothy J Henrich, Brian R Wood, Daniel R Kuritzkes
Published 2012-01-01

Short and long-term effects of telaprevir on kidney function in patients with hepatitis C virus infection: a retrospective cohort study.

by Meghan E Sise, Elke S Backman, Julia B Wenger, Brian R Wood, Paul E Sax, Raymond T Chung, Ravi Thadhani, Arthur Y Kim
Published 2015-01-01

Conflicting effects of atazanavir therapy on atherosclerotic risk factors in stable HIV patients: A randomized trial of regimen switch to atazanavir.

by Joshua A Beckman, Brian R Wood, Kevin L Ard, Christin N Price, Daniel A Solomon, Jonah P Zuflacht, Jessica Milian, Joshua C Prenner, Paul E Sax
Published 2017-01-01